Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2007 1
2009 1
2010 1
2011 2
2013 1
2014 2
2016 1
2017 2
2018 1
2019 1
2020 9
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Cancer immunotherapy-related adverse events: causes and challenges.
Blidner AG, Choi J, Cooksley T, Dougan M, Glezerman I, Ginex P, Girotra M, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Rapoport BL, Anderson R. Blidner AG, et al. Among authors: girotra m. Support Care Cancer. 2020 Dec;28(12):6111-6117. doi: 10.1007/s00520-020-05705-5. Epub 2020 Aug 28. Support Care Cancer. 2020. PMID: 32857220 Review.
Anabolic skeletal therapy for osteoporosis.
Girotra M, Rubin MR, Bilezikian JP. Girotra M, et al. Arq Bras Endocrinol Metabol. 2006 Aug;50(4):745-54. doi: 10.1590/s0004-27302006000400019. Arq Bras Endocrinol Metabol. 2006. PMID: 17117299 Review.
The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management.
Girotra M, Hansen A, Farooki A, Byun DJ, Min L, Creelan BC, Callahan MK, Atkins MB, Sharon E, Antonia SJ, West P, Gravell AE; Investigational Drug Steering Committee (IDSC) Immunotherapy Task Force collaboration. Girotra M, et al. JNCI Cancer Spectr. 2018 Jul;2(3):pky021. doi: 10.1093/jncics/pky021. Epub 2018 Jul 19. JNCI Cancer Spectr. 2018. PMID: 30057972 Free PMC article. Review.
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitors.
Choi J, Anderson R, Blidner A, Cooksley T, Dougan M, Glezerman I, Ginex P, Girotra M, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Rapoport BL, Lacouture ME. Choi J, et al. Among authors: girotra m. Support Care Cancer. 2020 Dec;28(12):6119-6128. doi: 10.1007/s00520-020-05706-4. Epub 2020 Aug 27. Support Care Cancer. 2020. PMID: 32856211 Free PMC article. Review.
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicities.
Cooksley T, Girotra M, Ginex P, Gordon RA, Anderson R, Blidner A, Choi J, Dougan M, Glezerman I, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Rapoport BL. Cooksley T, et al. Among authors: girotra m. Support Care Cancer. 2020 Dec;28(12):6175-6181. doi: 10.1007/s00520-020-05709-1. Epub 2020 Aug 27. Support Care Cancer. 2020. PMID: 32856213 Review.
23 results